ArticleJournal for immunotherapy of cancer2021

Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial.

Carlos Jiménez-Cortegana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.